AzTrials
AzTrials

HypertensionMICNCT05555095

Examining Digital Health Care Delivery Models Through Medicaid Collaborative

An observational study of Hypertension and Diabetes Mellitus, run by OSF Healthcare System at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The purpose of this study is to examine the intervention effectiveness and dissemination of digital health care delivery models for improving selected health outcomes in the Medicaid population. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hypertension, Diabetes Mellitus, Maternal Health
What is being tested?
digital health delivered multicomponent intervention
How many people
22,340 participants
Where
1 siteUnited States
Study dates
26 Sep 2022to 31 Dec 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population will be comprised of individuals who are enrolled in a digital health care delivery model for improving selected health outcomes in the Medicaid population. The population will be obtained from the cohorts as listed above. All those enrolled in the MIC program will be strategically identified and used as the population from which to draw the sample for the quantitative and qualitative portions of the study.

Who may be able to join

  • Patient of one of four medically qualified health care centers and/or OSF HealthCare as defined by insurance type
  • Insured by Medicaid or dually eligible for Medicare or Medicaid
  • Has one or more of the three following conditions:
  • Hypertension, Diabetes Mellitus, or Pregnancy
  • Able to read and understand English or read translated materials in language provided (e.g. Spanish)
  • Minors who are pregnant and less 18 years of age who are enrolled in the MIC Program

Who cannot join

  • Not enrolled in the MIC Program
  • No one will be excluded on basis of sex or race

Trial locations and contacts

1 site in 1 country.

United States1 site
  • OSF HealthCare System

    Peoria, Illinois, 61602

Other trials in United States

About this study

Official title: The Medicaid Innovation Collaborative (MIC) Experience: Transforming Care Through Digital Health: A Mixed Methods Analysis

The purpose of this study is to examine the intervention effectiveness and dissemination of digital health care delivery models for improving selected health outcomes in the Medicaid population.

Read the detailed description

The investigators will conduct a mixed method study that includes a controlled interrupted times series (CITS) design to study hypertension (HTN) and diabetes, a cohort to study pregnancy, and longitudinal patient and provider interviews to study experiences. This approach is appropriate when randomization is not desirable or feasible and is frequently utilized for evaluation of public health interventions (Lopez Bernal et al., 2018; Hategeka et al., 2020).

Being tested
digital health delivered multicomponent intervention
Keywords
hypertension, diabetes, maternal health, digital health
Medical subject headings
Hypertension, Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • digital health delivered multicomponent interventionBehavioural

    Also called Digital Care Solution as supportive personalized care

    The MIC program will have set minimum levels of connectivity for each of the three defined conditions under study.

Study groups in NCT05555095
Study groupRoleWhat they receive
OSF HealthCareSubjects from OSF HealthCare
Receives: Behavioral: digital health delivered multicomponent intervention
Federally Qualified Health Center (FQHC) - 1Subjects from Eagle View Community Health System enrolled in MIC Program
Receives: Behavioral: digital health delivered multicomponent intervention
Federally Qualified Health Center (FQHC) - 2Subjects from Chestnut Health System Inc. enrolled in MIC Program
Receives: Behavioral: digital health delivered multicomponent intervention
Federally Qualified Health Center (FQHC) - 3Subjects from Heartland Community Health System enrolled in MIC Program
Receives: Behavioral: digital health delivered multicomponent intervention
Federally Qualified Health Center (FQHC) - 4Subjects from Aunt Martha's enrolled in MIC Program
Receives: Behavioral: digital health delivered multicomponent intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in participant's blood pressure control at three points in time

    Decrease in the average systolic and/or diastolic blood pressure

    Measured: 3 months, 6 months, 12 months

  2. Change in participant's glycemic control at three points in time

    Defined as a reduction >1% in glycosylated hemoglobin (hemoglobin A1C)

    Measured: 3 months, 6 months, 12 months

  3. Change in Patient Assessment of Chronic Illness Care scale (PACIC) from baseline to exit from program

    Measure of patient's perception of care management for chronic disease - 20 items on a 5-point scale 1=no or never to 5=Always, with higher score indicating better care

    Measured: baseline, end of program, on average of 1 year

  4. Change in Patient Perception of Health Care Management (adapted form of PACIC to reflect pre/postnatal care) from baseline to exit from program

    Measure of patient-centered care and self-management - 20 items on a 5-point scale 1=no or never to 5=Always, with higher score indicating better care

    Measured: baseline, end of program, on average 6 months

  5. Patient satisfaction, 1-item researcher generated question

    Measure of patient's satisfaction, Participant's recommendation of program to others (Yes/No)

    Measured: at exit from program, on average 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Sep 2022
  2. Study start26 Sep 2022
  3. Primary completion31 Dec 2028 (estimated)
  4. Study completion31 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
22,340 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05555095
Sponsor's protocol ID
1876230
Acronym
MIC
Status last verified
Oct 2026
First submitted
19 Sep 2022
Last updated
19 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Aung E, Ostini R, Dower J, Donald M, Coll JR, Williams GM, Doi SA. Patient Assessment of Chronic Illness Care (PACIC) in Type 2 Diabetes: A Longitudinal Study. Eval Health Prof. 2016 Jun;39(2):185-203. doi: 10.1177/0163278714556674. Epub 2014 Nov 6.

    PubMed 25380699
  • Cooling M, Klein CJ, Pierce LM, Delinski N, Lotz A, Vozenilek JA. Access to Care: End-to-End Digital Response for COVID-19 Care Delivery. J Nurse Pract. 2022 Feb;18(2):232-235. doi: 10.1016/j.nurpra.2021.09.011. Epub 2021 Sep 25.

    PubMed 34608377
  • Dalstrom M, Weinzimmer LG, Foulger R, Klein CJ. Medicaid expansion and accessibility to healthcare: The Illinois experience. Public Health Nurs. 2021 Sep;38(5):720-729. doi: 10.1111/phn.12899. Epub 2021 Mar 29.

    PubMed 33778982
  • Etminani K, Goransson C, Galozy A, Norell Pejner M, Nowaczyk S. Improving Medication Adherence Through Adaptive Digital Interventions (iMedA) in Patients With Hypertension: Protocol for an Interrupted Time Series Study. JMIR Res Protoc. 2021 May 12;10(5):e24494. doi: 10.2196/24494.

    PubMed 33978593
  • Hategeka C, Ruton H, Karamouzian M, Lynd LD, Law MR. Use of interrupted time series methods in the evaluation of health system quality improvement interventions: a methodological systematic review. BMJ Glob Health. 2020 Oct;5(10):e003567. doi: 10.1136/bmjgh-2020-003567.

    PubMed 33055094
  • Kangovi S, Mitra N, Norton L, Harte R, Zhao X, Carter T, Grande D, Long JA. Effect of Community Health Worker Support on Clinical Outcomes of Low-Income Patients Across Primary Care Facilities: A Randomized Clinical Trial. JAMA Intern Med. 2018 Dec 1;178(12):1635-1643. doi: 10.1001/jamainternmed.2018.4630.

    PubMed 30422224
  • Nijagal MA, Wissig S, Stowell C, Olson E, Amer-Wahlin I, Bonsel G, Brooks A, Coleman M, Devi Karalasingam S, Duffy JMN, Flanagan T, Gebhardt S, Greene ME, Groenendaal F, R Jeganathan JR, Kowaliw T, Lamain-de-Ruiter M, Main E, Owens M, Petersen R, Reiss I, Sakala C, Speciale AM, Thompson R, Okunade O, Franx A. Standardized outcome measures for pregnancy and childbirth, an ICHOM proposal. BMC Health Serv Res. 2018 Dec 11;18(1):953. doi: 10.1186/s12913-018-3732-3.

    PubMed 30537958
  • Roman LA, Raffo JE, Dertz K, Agee B, Evans D, Penninga K, Pierce T, Cunningham B, VanderMeulen P. Understanding Perspectives of African American Medicaid-Insured Women on the Process of Perinatal Care: An Opportunity for Systems Improvement. Matern Child Health J. 2017 Dec;21(Suppl 1):81-92. doi: 10.1007/s10995-017-2372-2.

    PubMed 28965183
  • Williams JS, Walker RJ, Egede LE. Achieving Equity in an Evolving Healthcare System: Opportunities and Challenges. Am J Med Sci. 2016 Jan;351(1):33-43. doi: 10.1016/j.amjms.2015.10.012.

    PubMed 26802756
  • Lopez Bernal J, Cummins S, Gasparrini A. The use of controls in interrupted time series studies of public health interventions. Int J Epidemiol. 2018 Dec 1;47(6):2082-2093. doi: 10.1093/ije/dyy135.

    PubMed 29982445
  • Cooling M, Klein CJ, Dalstrom MD, Foulger R, Junis J, Handler JA. Increasing access to care through digital health for the Medicaid population: a novel community case study. Front Digit Health. 2025 Sep 19;7:1524590. doi: 10.3389/fdgth.2025.1524590. eCollection 2025.

    PubMed 41049159
  • Klein CJ, Dalstrom M, Bond WF, McGarvey J, Cooling M, Zumpf K, Pierce L, Stoecker B, Handler JA. The feasibility of implementing a digital pregnancy and postpartum support program in the Midwestern United States and the association with maternal and infant health. Prev Med Rep. 2024 Dec 20;49:102953. doi: 10.1016/j.pmedr.2024.102953. eCollection 2025 Jan.

    PubMed 39834381
  • Dalstrom MD, Cioni J, Klein CJ, Cooling M. Examining digital care relationships of medicaid participants in the pre/postnatal care period: a qualitative study. BMC Pregnancy Childbirth. 2025 Apr 23;25(1):473. doi: 10.1186/s12884-025-07587-z.

    PubMed 40269798
  • Dalstrom MD, Jordan S, Klein CJ, Cooling M. Examining a Remote Patient Monitoring Program with Medicaid Patients Managing Diabetes and Hypertension: A Qualitative Study. J Patient Exp. 2026 Jan 14;13:23743735251414380. doi: 10.1177/23743735251414380. eCollection 2026.

    PubMed 41551717

Questions about this trial

What is this clinical trial studying?

An observational study of Hypertension and Diabetes Mellitus, run by OSF Healthcare System at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 19 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in participant's blood pressure control at three points in time (time frame: 3 months, 6 months, 12 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05555095, which also lists 14 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in